We report net peptide content, not just purity — so the milligrams you dose aren't padded with water and counter-ion. RP-HPLC purity and ESI-MS identity, on a lot-numbered COA.
Net peptide content, not just purity — RP-HPLC + ESI-MS, lot-numbered COA.
Net peptide content on every lot's COA.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Long-acting GHRH analog with Drug Affinity Complex
Lyochem buyer fit
This Lyochem page is intentionally written for research labs, core facilities, and method-development teams qualifying CJC-1295 with DAC as a reference-grade lot. It is not the pharmacy procurement owner for this SKU; the page should win differentiated searches around sequence verification, assay suitability, lot continuity, and data-packet depth.
Overview
Belonging to the Modified GRF 1-29 family, CJC-1295 with DAC achieves its extended duration through a maleimido-propionyl group installed at Lys30, which reacts covalently with Cys34 on circulating serum albumin, the Drug Affinity Complex (DAC) principle. Anchoring to albumin stretches the plasma half-life from the roughly 30 minutes of the no-DAC peptide out to approximately 6-8 days, which is what enables once-weekly regimens in research and compounding settings. Lyochem supplies CJC-1295 with DAC as the lyophilized acetate reference standard at ≥99.0% HPLC. This variant demands stricter identity work than the no-DAC form, because a partially hydrolyzed maleimide co-elutes at the same retention time and clears the standard purity gate while having lost its albumin-conjugating capacity, so the modification must be verified intact at the labeled position. Release therefore combines peak-integration HPLC with ESI-MS confirming the modified mass; at first-time supplier qualification we additionally recommend a thiol-reactivity assay against a reference thiol to prove maleimide integrity. The prolonged exposure profile favors sustained-elevation GH studies, whereas pulse-pharmacology work that must preserve native secretory architecture is better served by the no-DAC form.
Applications & buyer fit
GH-axis peptides ship to research labs studying somatotropic-pathway pharmacology, IGF-axis signalling, and pulse vs. sustained-elevation GH biology. Buyers qualifying a new source typically request sequence verification on the first lot, the counter-ion form (acetate by default), and stability data at −20 °C. Blends — the CJC-1295 + Ipamorelin co-formulated lot is the canonical example — are co-lyophilised rather than solution-mixed so the ratio is locked at the lyophilisation step.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Every release ships with its own batch-specific CoA — identity, purity, and the analytical scope agreed at quote stage, tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Specifications
Documentation available on request
Regulatory note
Sold for Research Use Only under the receiving laboratory's institutional and jurisdictional regulations. Not a finished dosage form, not labelled for human administration — Lyochem's GH-axis lots are scoped to research workflows only. Buyers studying somatotropic pharmacology should specify the counter-ion form (acetate by default) and any pulse-vs-sustained study design notes at quote stage.
Selected literature
Frequently asked questions
The functional group is a maleimide at Lys30; on storage it can hydrolyze to an open-ring carboxylic acid that sits at nearly the same retention time and only a small mass increment away, so routine RP-HPLC and ESI-MS may report the batch as conforming while the albumin-binding capacity is gone. The definitive characterization is a reactivity assay: incubate the material with a reference thiol such as cysteine or N-acetyl-cysteine and confirm covalent adduct formation. Running this at first supplier qualification, and on any lot with stability doubts, verifies the maleimide is still intact.
Maleimide ring-opening is accelerated by moisture and mishandling, so the lyophilized standard should be kept dry and cold, brought to room temperature before opening to avoid condensation, and reconstituted promptly. For a material used as a comparator, the certificate should ideally report the fraction of intact versus hydrolyzed species, not merely an overall HPLC purity, because those two forms are chromatographically close yet functionally distinct. Documenting the thiol-reactivity result alongside the mass and purity gives downstream users a defensible basis for treating the conjugate as active reference material.
Related peptides
Modified GRF 1-29 · GHRH analog
Ghrelin / GHSR pathway GH-release peptide
29-mer
GHRH 1-29 fragment